SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-033935
Filing Date
2024-04-18
Accepted
2024-04-18 07:42:32
Documents
71
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0202767-10k_bespoke.htm   iXBRL 10-K 813930
2 SUBSIDIARIES: BESPOKE EXTRACTS COLORADO, LLC (COLORADO) ea020276701ex21-1_bespoke.htm EX-21.1 476
3 CERTIFICATION ea020276701ex31-1_bespoke.htm EX-31.1 11741
4 CERTIFICATION ea020276701ex32-1_bespoke.htm EX-32.1 3407
5 GRAPHIC fin_001.jpg GRAPHIC 6583
6 GRAPHIC fin_002.jpg GRAPHIC 5120
  Complete submission text file 0001213900-24-033935.txt   4870597

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE bspk-20231231.xsd EX-101.SCH 56015
8 XBRL CALCULATION FILE bspk-20231231_cal.xml EX-101.CAL 34458
9 XBRL DEFINITION FILE bspk-20231231_def.xml EX-101.DEF 267183
10 XBRL LABEL FILE bspk-20231231_lab.xml EX-101.LAB 490757
11 XBRL PRESENTATION FILE bspk-20231231_pre.xml EX-101.PRE 262746
75 EXTRACTED XBRL INSTANCE DOCUMENT ea0202767-10k_bespoke_htm.xml XML 369180
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52759 | Film No.: 24852879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)